{"log_id": 2514465235143200257, "direction": 0, "words_result_num": 38, "words_result": [{"probability": {"variance": 3e-06, "average": 0.998825, "min": 0.994267}, "location": {"width": 348, "top": 191, "height": 40, "left": 170}, "words": "可能发生欣快感增强,导致精神依赖增强"}, {"probability": {"variance": 0.001103, "average": 0.983913, "min": 0.872742}, "location": {"width": 202, "top": 232, "height": 29, "left": 176}, "words": "CYP450抑制剂和诱导剂"}, {"probability": {"variance": 0.00031, "average": 0.993203, "min": 0.900333}, "location": {"width": 794, "top": 243, "height": 57, "left": 208}, "words": "抑制细胞色素P450的化合物可能加强像唑吡坦这样的安眠药的活性。唑吡坦通过一些肝脏细胞"}, {"probability": {"variance": 0.011715, "average": 0.966262, "min": 0.41071}, "location": {"width": 835, "top": 277, "height": 61, "left": 168}, "words": "色素P450酶代谢,主要的酶是CYP3A4和CYP1A2的促进作用。与利福平(一种CYP3A4诱导剂)同"}, {"probability": {"variance": 0.000501, "average": 0.98883, "min": 0.878927}, "location": {"width": 833, "top": 314, "height": 57, "left": 172}, "words": "时给药时,唑吡坦的药效学作用被降低。但是,当唑吡坦与依曲康唑(种CYP3A4抑制剂)同时给药"}, {"probability": {"variance": 0.000742, "average": 0.993761, "min": 0.820794}, "location": {"width": 835, "top": 348, "height": 58, "left": 173}, "words": "时,它的药代动力学和药效学没有明显改变。这些结果的临床相关性不明确。同时使用唑吡坦与酮"}, {"probability": {"variance": 0.004199, "average": 0.981457, "min": 0.558833}, "location": {"width": 831, "top": 383, "height": 56, "left": 176}, "words": "康唑(一种CYP3A4抑制剂)(200mg每天两次)和唑吡坦加安慰剂相比,延迟唑坦的消除半衰"}, {"probability": {"variance": 0.000127, "average": 0.99454, "min": 0.948331}, "location": {"width": 830, "top": 416, "height": 56, "left": 177}, "words": "期,增加总的AUC,并降低表观口服清除率。合并使用酮康唑与单独使用唑吡坦相比,唑吡坦的总"}, {"probability": {"variance": 0.002009, "average": 0.987277, "min": 0.747437}, "location": {"width": 829, "top": 450, "height": 57, "left": 179}, "words": "AUC提高1.83倍。一般认为不需要对唑吡坦进行常规的剂量调整,但是应该建议患者在同时使用唑"}, {"probability": {"variance": 0.002953, "average": 0.984032, "min": 0.780778}, "location": {"width": 295, "top": 503, "height": 36, "left": 179}, "words": "吡坦与酮康唑时镇静作用可能增强"}, {"probability": {"variance": 0, "average": 0.999563, "min": 0.999328}, "location": {"width": 83, "top": 545, "height": 26, "left": 179}, "words": "其他药物"}, {"probability": {"variance": 0.000638, "average": 0.993293, "min": 0.839716}, "location": {"width": 794, "top": 552, "height": 54, "left": 219}, "words": "唑吡坦与华法林、地高辛、雷尼替丁或西米替丁同时给药时,没有观察到明显的药代动力学相"}, {"probability": {"variance": 0, "average": 0.999275, "min": 0.998819}, "location": {"width": 61, "top": 613, "height": 24, "left": 184}, "words": "互作用"}, {"probability": {"variance": 5e-06, "average": 0.998308, "min": 0.993327}, "location": {"width": 109, "top": 646, "height": 26, "left": 188}, "words": "【药物过量】"}, {"probability": {"variance": 1e-06, "average": 0.99937, "min": 0.99799}, "location": {"width": 103, "top": 681, "height": 26, "left": 185}, "words": "体征和症状"}, {"probability": {"variance": 7.5e-05, "average": 0.995939, "min": 0.959747}, "location": {"width": 790, "top": 689, "height": 55, "left": 223}, "words": "曾有报告在唑吡坦单独用药或者合并使用其他CNS抑制剂(包括酒精)用药过量时,发生意识"}, {"probability": {"variance": 5e-06, "average": 0.998902, "min": 0.989819}, "location": {"width": 429, "top": 738, "height": 40, "left": 185}, "words": "损伤直到昏迷和更为严重的症状,包括致死的结果"}, {"probability": {"variance": 0, "average": 0.999598, "min": 0.999576}, "location": {"width": 44, "top": 786, "height": 24, "left": 188}, "words": "处理"}, {"probability": {"variance": 3.1e-05, "average": 0.997644, "min": 0.974511}, "location": {"width": 789, "top": 791, "height": 53, "left": 225}, "words": "应该使用一般的对症和支持措施。如果胃排空无效,应该给予活性炭减少吸收。即使出现兴奋"}, {"probability": {"variance": 0.002081, "average": 0.991015, "min": 0.696412}, "location": {"width": 825, "top": 825, "height": 54, "left": 191}, "words": "也应停用镇静药。在观察到严重症状时可以考虑使用氟马西尼。但是,给予氟马西尼可能促发神经"}, {"probability": {"variance": 0.000149, "average": 0.989129, "min": 0.968096}, "location": {"width": 130, "top": 886, "height": 25, "left": 192}, "words": "学症状(癫痫)"}, {"probability": {"variance": 7.6e-05, "average": 0.993152, "min": 0.978504}, "location": {"width": 139, "top": 917, "height": 29, "left": 231}, "words": "唑吡坦不可透析"}, {"probability": {"variance": 1e-06, "average": 0.998989, "min": 0.997799}, "location": {"width": 104, "top": 955, "height": 25, "left": 200}, "words": "【药理毒理】"}, {"probability": {"variance": 6e-06, "average": 0.997221, "min": 0.993371}, "location": {"width": 81, "top": 990, "height": 25, "left": 194}, "words": "药理作用"}, {"probability": {"variance": 8.7e-05, "average": 0.995623, "min": 0.96436}, "location": {"width": 792, "top": 996, "height": 54, "left": 235}, "words": "唑吡坦是一种与苯二氮卓类有关的咪唑吡啶类催眠药物,其药效学活性本质上类似于其它同类"}, {"probability": {"variance": 1.4e-05, "average": 0.998516, "min": 0.978982}, "location": {"width": 573, "top": 1040, "height": 45, "left": 198}, "words": "化合物的作用:肌肉松弛、抗焦虑、镇静、催眠、抗惊厥、引起遗忘"}, {"probability": {"variance": 2.3e-05, "average": 0.997512, "min": 0.975114}, "location": {"width": 795, "top": 1063, "height": 55, "left": 235}, "words": "实验研究已经证明镇静作用所需的剂量低于抗惊厥、肌肉松弛和抗焦虑作用所需的剂量。这些"}, {"probability": {"variance": 0.003385, "average": 0.981549, "min": 0.670658}, "location": {"width": 823, "top": 1097, "height": 55, "left": 198}, "words": "作用与对中枢受体的特异激动作用有关,后者属于 gaba-omega(BZl和BZ)大分子受体复合体"}, {"probability": {"variance": 1.7e-05, "average": 0.997526, "min": 0.984106}, "location": {"width": 275, "top": 1149, "height": 36, "left": 199}, "words": "具有调节氯离子通道开放的作用"}, {"probability": {"variance": 0.006994, "average": 0.957654, "min": 0.654369}, "location": {"width": 431, "top": 1177, "height": 41, "left": 240}, "words": "唑吡坦选择性地结合于 Omega(或BZl)亚型受体"}, {"probability": {"variance": 0.00709, "average": 0.979725, "min": 0.473184}, "location": {"width": 795, "top": 1199, "height": 53, "left": 240}, "words": "在人类,唑吡坦缩短入睡所需的时间,减少夜间醒来的次数,增加总的睡眠持续时间并改善睡"}, {"probability": {"variance": 0.012964, "average": 0.965586, "min": 0.39346}, "location": {"width": 897, "top": 1225, "height": 97, "left": 203}, "words": "眠质量。这些作用伴随着特征性的脑电图波形,与苯二氮卓类药物诱导的脑电图有所个NQ ANGZ HO"}, {"probability": {"variance": 0.003035, "average": 0.979633, "min": 0.71565}, "location": {"width": 839, "top": 1260, "height": 64, "left": 203}, "words": "眠记录研究已经证明:唑吡坦延长Ⅱ期睡眠和深睡眠(Ⅲ和IⅣ期)。在推荐剂量影"}, {"probability": {"variance": 0.000121, "average": 0.992294, "min": 0.964867}, "location": {"width": 321, "top": 1318, "height": 37, "left": 205}, "words": "异相睡眠总的持续时间(快动眼睡眠)"}, {"probability": {"variance": 0, "average": 0.999108, "min": 0.998234}, "location": {"width": 81, "top": 1363, "height": 23, "left": 207}, "words": "毒理研究"}, {"probability": {"variance": 0.006703, "average": 0.982543, "min": 0.469499}, "location": {"width": 760, "top": 1370, "height": 52, "left": 239}, "words": "遗传毒性:唑吡坦Ames试验、小鼠淋巴瘤细胞遗传毒性试验、人淋巴细胞染色体畸变试验"}, {"probability": {"variance": 0.000152, "average": 0.9935, "min": 0.942892}, "location": {"width": 517, "top": 1411, "height": 47, "left": 209}, "words": "鼠肝细胞程序外DNA合成试验和小鼠微核试验结果均为阴性"}, {"probability": {"variance": 2.3e-05, "average": 0.997116, "min": 0.980805}, "location": {"width": 702, "top": 1440, "height": 49, "left": 242}, "words": "生殖毒性:大鼠一般生殖毒性试验中,高剂量组(100mg碱kg)大鼠出现发情期不"}], "language": 3}